SCHEMBL8338265

SCHEMBL8338265

Cc1ccc(NC(=O)C(NC(=O)OC(C)(C)C)c2ccccc2)cc1C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.52
CTSK P43235 1/20 0.52
TAS2R14 Q9NYV8 1/20 0.45
BACE1 P56817 5/20 0.45
S1PR3 Q99500 1/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
GABRB1 P18505 1/20 0.42
GABRB2 P47870 1/20 0.42
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8337969 0.88 CTSS (0.57) CTSSCTSKBACE1S1PR3ALDH1A1
SCHEMBL8338577 0.88 CTSS (0.57) CTSSCTSKBACE1S1PR3ALDH1A1
SCHEMBL6726454 0.88 TAS2R14 (0.51) TAS2R14BACE1S1PR3ALDH1A1CYP1A2
SCHEMBL8328339 0.83 CTSS (0.57) CTSSCTSKBACE1S1PR3POLB
SCHEMBL8337364 0.83 SMN1; SMN2 (0.58) CTSSCTSKBACE1S1PR3ALDH1A1
SCHEMBL8336482 0.83 SMN1; SMN2 (0.58) CTSSCTSKBACE1S1PR3ALDH1A1
SCHEMBL8336332 0.82 CTSS (0.60) CTSSCTSKBACE1S1PR3ALDH1A1
SCHEMBL31048635 0.81 CTSK (0.66) CTSSCTSKBACE1S1PR3POLB
SCHEMBL8338149 0.81 CTSK (0.66) CTSSCTSKBACE1S1PR3POLB
SCHEMBL6715868 0.81 CTSS (0.57) CTSSCTSKBACE1S1PR3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022528-A2 ARYLGLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed